High insulinlike growth factor I is associated with cognitive decline in Huntington disease.
about
Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMAReducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice.Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease.IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington diseaseA 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease.Cognitive impairment in Huntington disease: diagnosis and treatment.The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer's disease: relationship with cognitive function.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.
P2860
Q26772966-748BF4F3-E327-4345-AE4B-2A9BB6CA2918Q34070946-2858BC8A-5FFF-4622-897D-C782CAB2C24EQ34537073-180A4E9A-E131-43CE-9CCB-ADA95086B8E6Q35370058-708F980D-76E6-4600-B512-9B76AD8C9458Q35797126-889C1A33-24CE-4695-B7F2-2058CB962331Q36011977-5561DFCF-240C-4286-8691-369E7CC70DA9Q36056302-1C4E199A-4F21-4DA1-AD98-BAB33D4BE707Q36132651-82993855-A4D8-487A-9258-E34A2744CE2FQ36773397-152B2129-7239-4C98-AA9F-9325E77C5A03Q38202178-73A7CE08-A849-4FA5-AC01-B2CF1D365FBDQ38993673-A7BFE6DB-E7EB-4BC5-9415-EADD67A9F768Q45296557-035DC90D-2E16-4F2B-96EA-7A6E98E1EE73Q46309597-73EF73D6-63D1-4D9F-A9C9-BC1B5D7F71D5Q50561209-36FE0C24-D7F2-417F-8B54-1ECAE117B38FQ52721984-B8E77CBD-2F22-46CD-8AFE-9CE9EA6DCB4D
P2860
High insulinlike growth factor I is associated with cognitive decline in Huntington disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High insulinlike growth factor ...... decline in Huntington disease.
@en
High insulinlike growth factor ...... decline in Huntington disease.
@nl
type
label
High insulinlike growth factor ...... decline in Huntington disease.
@en
High insulinlike growth factor ...... decline in Huntington disease.
@nl
prefLabel
High insulinlike growth factor ...... decline in Huntington disease.
@en
High insulinlike growth factor ...... decline in Huntington disease.
@nl
P2093
P50
P1433
P1476
High insulinlike growth factor ...... decline in Huntington disease
@en
P2093
Huntington French Speaking Group
J-P Azulay
N El Hawajri
S Moutereau
P356
10.1212/WNL.0B013E3181E62076
P407
P577
2010-07-01T00:00:00Z